Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors - US Institutional
For Institutional Investors in the US

Global Life Sciences Fund Holdings

Full Portfolio Holdings

(As of May 31, 2026)

% OF INVESTMENTS
Eli Lilly & Co 9.71
Johnson & Johnson 6.79
UnitedHealth Group Inc 4.22
AstraZeneca PLC 4.19
AbbVie Inc 3.95
REVOLUTION Medicines Inc 3.13
Novartis AG (ADR) 2.67
Argenx SE (ADR) 2.61
Praxis Precision Medicines Inc 2.43
Thermo Fisher Scientific Inc 2.42
Roche Holding AG 2.25
Intuitive Surgical Inc 2.18
Abbott Laboratories 1.91
Bridgebio Pharma Inc 1.90
Vertex Pharmaceuticals Inc 1.89
Merck & Co Inc 1.84
CVS Health Corp 1.80
Sanofi SA 1.77
Danaher Corp 1.69
Amgen Inc 1.67
Ascendis Pharma A/S 1.54
Stryker Corp 1.49
PTC Therapeutics Inc 1.42
Gilead Sciences Inc 1.39
Boston Scientific Corp 1.38
Madrigal Pharmaceuticals Inc 1.35
HCA Healthcare Inc 1.34
Mirum Pharmaceuticals Inc 1.29
Travere Therapeutics Inc 1.26
Teva Pharmaceutical Industries Ltd (ADR) 1.25
United Therapeutics Corp 1.20
Elevance Health Inc 1.17
Globus Medical Inc 1.13
McKesson Corp 1.04
Lantheus Holdings Inc 0.95
Vaxcyte Inc 0.91
Dyne Therapeutics Inc 0.90
Edwards Lifesciences Corp 0.81
Medtronic PLC 0.76
Apogee Therapeutics Inc 0.70
DexCom Inc 0.64
Cencora Inc 0.62
UCB SA 0.62
Medline Inc 0.58
Becton Dickinson & Co 0.48
Spyre Therapeutics Inc 0.48
Edgewise Therapeutics Inc 0.43
Biohaven Ltd 0.43
Glaukos Corp 0.41
Structure Therapeutics Inc (ADR) 0.40
Ideaya Biosciences Inc 0.40
Neurocrine Biosciences Inc 0.40
Tarsus Pharmaceuticals Inc 0.39
Centene Corp 0.38
Penumbra Inc 0.36
Heartflow Inc 0.36
Xenon Pharmaceuticals Inc 0.35
Curevo Inc 0.34
Cogent Biosciences Inc 0.33
STERIS PLC 0.32
Daiichi Sankyo Co Ltd 0.31
Cooper Cos Inc 0.31
Illumina Inc 0.31
Scholar Rock Holding Corp 0.30
Sotera Health Co 0.30
Protagonist Therapeutics Inc 0.29
Humana Inc 0.29
Regeneron Pharmaceuticals Inc 0.27
Rhythm Pharmaceuticals Inc 0.26
Crinetics Pharmaceuticals Inc 0.26
Insulet Corp 0.25
Insmed Inc 0.25
Ardelyx Inc 0.25
Nuvalent Inc 0.25
Alnylam Pharmaceuticals Inc 0.24
MIRUM PHARMACEUTICALS 0.23
Teleflex Inc 0.23
Oruka Therapeutics Inc 0.23
KARDIUM SERIES 8 CLASS D PREFERRED SHARES USD 0.23
Loadsmart Inc 0.23
Janux Therapeutics Inc 0.18
Olema Pharmaceuticals Inc 0.16
4D Molecular Therapeutics Inc 0.15
Green Cross Holdings Corp 0.15
Immunome Inc 0.11
Definium Therapeutics Inc 0.11
Lexeo Therapeutics Inc 0.06
Magnolia Medical Technologies Inc 0.05
Element Biosciences Inc 0.05
PFIZER INC 0.04
Twinstrand Biosciences Inc 0.03
Freenome Holdings Inc 0.02
Freenome Holdings Inc 0.02
Sonoma Biotherapeutics Inc 0.02
Asher Biotherapeutics Inc 0.02
Sonoma Biotherapeutics Inc 0.01
Attralus Inc 0.01
Asher Biotherapeutics Inc 0.01
Novo Nordisk A/S 0.01
Hemoshear Therapeutics LLC 0.01
Alkermes PLC 0.01
Cash & Equivalents 0.46
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.